Is treatment of nephropathy in type 1 diabetes efficacious but ineffective?

Editorial

Robert G Nelson. J Am Soc Nephrol. 2011 Mar.

. 2011 Mar;22(3):402-4.

doi: 10.1681/ASN.2011010076. Epub 2011 Feb 25.

No abstract available

Comment on

Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria.
Forsblom C, Harjutsalo V, Thorn LM, Wadén J, Tolonen N, Saraheimo M, Gordin D, Moran JL, Thomas MC, Groop PH; FinnDiane Study Group. Forsblom C, et al. J Am Soc Nephrol. 2011 Mar;22(3):537-44. doi: 10.1681/ASN.2010020194. Epub 2011 Feb 18. J Am Soc Nephrol. 2011. PMID: 21335512 Free PMC article.
Risk for ESRD in type 1 diabetes remains high despite renoprotection.
Rosolowsky ET, Skupien J, Smiles AM, Niewczas M, Roshan B, Stanton R, Eckfeldt JH, Warram JH, Krolewski AS. Rosolowsky ET, et al. J Am Soc Nephrol. 2011 Mar;22(3):545-53. doi: 10.1681/ASN.2010040354. Epub 2011 Feb 25. J Am Soc Nephrol. 2011. PMID: 21355053 Free PMC article.